Analysis of zebrafish periderm enhancers facilitates identification of a regulatory variant near human KRT8/18
- Wuhan University, China
- University of Iowa, United States
- University of Pittsburgh, United States
- Lawrence Berkeley Laboratories, United States
- DOE Joint Genome Institute, United States
- Emory University School of Medicine, United States
Abstract
Genome wide association studies for non-syndromic orofacial cleft (OFC) have identified single nucleotide polymorphisms (SNPs) at loci where the presumed risk-relevant gene is expressed in oral periderm. The functional subsets of such SNPs are difficult to predict because the sequence underpinnings of periderm enhancers are unknown. We applied ATAC-seq to models of human palate periderm, including zebrafish periderm, mouse embryonic palate epithelia, and a human oral epithelium cell line, and to complementary mesenchymal cell types. We identified sets of enhancers specific to the epithelial cells and trained gapped-kmer support-vector-machine classifiers on these sets. We used the classifiers to predict the effect of 14 OFC-associated SNPs at 12q13 near KRT18. All the classifiers picked the same SNP as having the strongest effect, but the significance was highest with the classifier trained on zebrafish periderm. Reporter and deletion analyses support this SNP as lying within a periderm enhancer regulating KRT18/KRT8 expression.
Data availability
1 Raw and processed sequencing data were deposited in GEO repository (GSE140241, GSE139945 and GSE139809).2 Custom scripts and piplines we deployed for sequencing data analysis and visualization are available at https://github.com/Badgerliu/periderm_ATACSeq.3 All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures.
-
Zebrafish periderm at 4-somite stageNCBI Gene Expression Omnibus, GSE140241.
-
ATAC-seq profile of mouse palatal epithelium at E14.5NCBI Gene Expression Omnibus, GSE139945.
-
Human oral epithelial cell line HIOECNCBI Gene Expression Omnibus, GSE139809.
-
ChIP-seq from embryonic facial prominence (ENCSR481SGM)NCBI Gene Expression Omnibus, GSE82727.
-
127-reference epigenome/25-state Imputation Based Chromatin State Model127-reference epigenome/25-state Imputation Based Chromatin State Model.
Article and author information
Author details
Jenna Colavincenzo Carlson
Funding
National Institutes of Health (DE023575)
- Robert A Cornell
National Institute for Health Research (DE027362)
- Robert A Cornell
National Institute of Dental and Craniofacial Research (DE025060)
- Elizabeth Leslie
National Institute of Dental and Craniofacial Research (DE024427)
- Axel Visel
National Institute of Dental and Craniofacial Research (DE028599)
- Axel Visel
National Natural Science Foundation of China (81771057)
- Huan Liu
National Natural Science Foundation of China (81400477)
- Huan Liu
Natural Science Foundation of Hubei Province (2017CFB515)
- Huan Liu
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: D. rerio were maintained in the University of Iowa Animal Care Facility according to a standard protocol (protocol no. 6011616). All mouse experiments were performed in accordance with approval of the Institutional Animal Care and Use Committees at the School and Hospital of Stomatology of Wuhan University (protocol no. 00271454).Mouse experiments for LacZ reporter transgenic animal work performed at the Lawrence Berkeley National Laboratory (LBNL) were reviewed and approved by the LBNL Animal Welfare and Research Committee.
Copyright
© 2020, Liu et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,118
- views
-
- 389
- downloads
-
- 24
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Analysis of zebrafish periderm enhancers facilitates identification of a regulatory variant near human KRT8/18
eLife 9:e51325.
https://doi.org/10.7554/eLife.51325
Further reading
-
- Computational and Systems Biology
The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.
